Thrombopoietic compounds

Details for Australian Patent Application No. 2007261362 (hide)

Owner Amgen Inc.

Inventors Gegg Jr., Colin V.; Tsai, Mei-mei; Sun, Jeonghoon; Walker, Kenneth W.; Galimi, Francesco; Min, Hosung

Agent Wrays

Pub. Number AU-A-2007261362

PCT Pub. Number WO2007/149529

Priority 60/844,301 13.09.06 US; 60/814,990 19.06.06 US; 11/820,463 18.06.07 US

Filing date 19 June 2007

Wipo publication date 27 December 2007

International Classifications

A61K 31/00 (2006.01)

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2007/149529 Priority application(s): WO2007/149529

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007261384-Electrode with increased stability and method of manufacturing the same

2007261356-Hexahydro-isoalpha acid based protein kinase modulation cancer treatment